Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Ibogaine Clinic Inc Unveils Details on Landmark Approach to Addiction Treatment through Dopamine Regulation

Playa del Carmen, Mexico (Newsworthy.ai) Wednesday Dec 27, 2023 @ 7:00 AM Eastern —

Ibogaine Clinic Inc, a pioneer in addiction treatment, has announced its cutting-edge approach to combating addiction by harnessing the unique properties of ibogaine, a natural occurring psychoactive substance, to regulate dopamine receptors, offering new hope for individuals struggling with addiction, depression, anxiety, and PTSD.

“After so many years successfully adapting our protocols to each individual's specific needs, we’ve had no shortage inquiries about the neurological functions on how we achieve it,” says facility founder Rabbi David Dardashti. “Ibogaine’s function on regulating dopamine receptors is one massive piece of the puzzle, which we incorporate with a wealth of other tools to achieve the desired healing result.”

Restoring Balance in the Brain

Ibogaine, derived from the roots of the iboga plant, is renowned for its ability to restore and modulate dopamine receptors in the brain. This psychoactive alkaloid increases levels of GABA (gamma-aminobutyric acid), inducing a calming effect on the brain. This mechanism significantly reduces cravings and withdrawal symptoms, common challenges in overcoming drug addiction.

Addressing the Root Cause of Addiction

Addictive substances alter the brain's dopamine system, responsible for pleasure, motivation, and movement, leading to tolerance and dependence. Ibogaine's interaction with various neurotransmitter systems, particularly the dopamine system, is critical. By inhibiting monoamine oxidase (MAO) activity, ibogaine increases dopamine availability, counteracting the harmful effects of chronic drug use on the brain's reward system.

A key aspect of Ibogaine Clinic Inc's approach is the activation of the D3 dopamine receptor, a crucial element in addiction development and relapse. Activation of this receptor has demonstrated reduced drug-seeking behavior in animal models, highlighting its potential in human treatments.

Promoting Neuroplasticity for Lasting Change

Beyond its immediate effects in helping the subject access and process their traumas, ibogaine promotes neuroplasticity – the brain's ability to adapt and change. This is vital in reversing the long-term changes caused by addictive drugs and restoring normal functionality to the dopamine system.

Ibogaine by David Dardashti’s innovative use of ibogaine represents a significant advancement in addiction therapy, and is continuing to foster in the future of the ibogaine movement. The natural substance’s ability to regulate dopamine and promote brain healing offers a promising path for those seeking an effective treatment for addiction and related disorders, but only when used under strict protocols by individuals with an impeccable track record of working with the substance, and under medical supervision.

For those who wish to learn more specifics about our protocols, or inquire about treatment, please call 1-800-818-4511.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Ibogaine Clinic Inc Unveils Details on Landmark Approach to Addiction Treatment through Dopamine Regulation.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.